StonvexLoading…
StonvexCore line items from HESM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.62B | $1.49B | $1.35B | $1.27B |
Operating Income | $1.01B | $919.00M | $816.90M | $791.20M |
Net Income | $352.90M | $223.10M | $118.60M | $83.90M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $4.39B | $4.15B | $3.79B | $3.59B |
Total Liabilities | $3.95B | $3.69B | $3.43B | $3.06B |
Cash & Equivalents | $1.90M | $4.30M | $5.40M | $3.10M |
Free Cash Flow OCF − CapEx | $728.20M | $634.20M | $642.90M | $622.90M |
Shares Outstanding | Not available | Not available | Not available | Not available |